Two pharmaceutical firms launch antidiabetic campaign in Dokdo

Handok Pharm and Novartis Korea launched an antidiabetic campaign in Dokdo, emphasizing a similar movement to protect pancreatic islet cell in the treatment of diabetes.

Located roughly halfway between Korea and Japan in the East Sea, the rocky islets have been at the center of a decade-old row between the two neighboring countries with both sides claiming them to be their own. The area surr...